APA

Arthur D. W., Winter K. A., Kuerer H. M., Haffty B., Cuttino L., Todor D. A., Anne P. R., Anderson P., Woodward W. A., McCormick B., Cheston S., Sahijdak W. M., Canaday D., Brown D. R., Currey A., Fisher C. M., Jagsi R., Moughan J. & White J. R. (20220310). Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial. : JAMA oncology.

Chicago

Arthur Douglas W, Winter Kathryn A, Kuerer Henry M, Haffty Bruce, Cuttino Laurie, Todor Dorin A, Anne Pramila Rani, Anderson Penny, Woodward Wendy A, McCormick Beryl, Cheston Sally, Sahijdak Walter M, Canaday Daniel, Brown Doris R, Currey Adam, Fisher Christine M, Jagsi Reshma, Moughan Jennifer and White Julia R. 20220310. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial. : JAMA oncology.

Harvard

Arthur D. W., Winter K. A., Kuerer H. M., Haffty B., Cuttino L., Todor D. A., Anne P. R., Anderson P., Woodward W. A., McCormick B., Cheston S., Sahijdak W. M., Canaday D., Brown D. R., Currey A., Fisher C. M., Jagsi R., Moughan J. and White J. R. (20220310). Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial. : JAMA oncology.

MLA

Arthur Douglas W, Winter Kathryn A, Kuerer Henry M, Haffty Bruce, Cuttino Laurie, Todor Dorin A, Anne Pramila Rani, Anderson Penny, Woodward Wendy A, McCormick Beryl, Cheston Sally, Sahijdak Walter M, Canaday Daniel, Brown Doris R, Currey Adam, Fisher Christine M, Jagsi Reshma, Moughan Jennifer and White Julia R. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial. : JAMA oncology. 20220310.